2024-10-19 - Analysis Report
## Thermo Fisher Scientific Inc. (TMO) Stock Analysis

**1. Performance Compared to S&P 500 (VOO)**

Thermo Fisher Scientific Inc. (TMO) is a leading provider of scientific instruments, reagents, and consumables for research, healthcare, and industrial markets. 

* **Cumulative Return:** TMO: 242.4%, VOO: 136.97%
* **Outperformance:** TMO has outperformed the S&P 500 by 105.43% (48.8% relative to its historical range of outperformance).

**2. Recent Price Movement**

* **Closing Price:** $599.25
* **5-Day Moving Average:** $598.41
* **20-Day Moving Average:** $604.66
* **60-Day Moving Average:** $607.32

The stock is currently trading slightly below its 20-day and 60-day moving averages, suggesting some short-term weakness. 

**3. Technical Indicators**

* **RSI:** 35.77 - This suggests the stock is currently in oversold territory.
* **PPO:** -0.17 - This indicates a bearish momentum.
* **Delta_Previous_Relative_Divergence:** -7.44 - This shows a recent decrease in the stock's relative outperformance compared to the S&P 500.
* **Expected Return:** 13.46% - This suggests a potential for above-average returns over the next 5 years compared to the S&P 500.

**4. Recent Earnings and Outlook**

| Date | EPS | Revenue | 
|---|---|---|
| 2024-08-02 | 4.05 | $10.54 B |
| 2024-05-03 | 3.47 | $10.35 B |
| 2023-11-03 | 4.44 | $10.57 B |
| 2023-08-04 | 3.53 | $10.69 B |
| 2024-08-02 | 3.53 | $10.69 B |

The most recent earnings for the quarter ending August 2, 2024, were slightly above analysts' expectations. Revenue also beat estimates, demonstrating consistent growth.  Overall, TMO continues to demonstrate a strong performance in terms of both earnings and revenue.

**5. News and Recent Developments**

* **FINBOLD** reports that TMO is experiencing a positive market outlook driven by strong demand for its products and services in the healthcare and life sciences industries. Analysts highlight its stable growth, robust balance sheet, and consistent dividend payments. 
* **Recent earnings call:** TMO management reiterated its commitment to sustainable growth and innovation, emphasizing the company's focus on developing new products and expanding into new markets. 

**6. Overall Analysis**

Thermo Fisher Scientific (TMO) continues to demonstrate a robust performance, exceeding the S&P 500 in both cumulative returns and projected future returns. Despite some recent weakness, the stock is well-positioned for continued growth driven by strong demand in its core markets and its commitment to innovation. The company's consistent financial performance and strong dividend make it an attractive investment opportunity for long-term investors.

**7. Disclaimer**
This analysis is for informational purposes only and should not be considered financial advice.  Please consult with a qualified financial advisor before making any investment decisions. 
